These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1024 related items for PubMed ID: 16950988

  • 1. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
    Gustafsson L, Hessel L, Storsaeter J, Olin P.
    Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
    [Abstract] [Full Text] [Related]

  • 2. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov.
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [Abstract] [Full Text] [Related]

  • 3. [Time for booster doses against whooping cough for 10-year-old children].
    Carlsson RM, Ekholm L, Gothefors L, Granström M, Trolin I, Tegnell A.
    Lakartidningen; 2005 Aug; 102(35):2394-8. PubMed ID: 16184889
    [Abstract] [Full Text] [Related]

  • 4. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.
    Nilsson L, Lepp T, von Segebaden K, Hallander H, Gustafsson L.
    Vaccine; 2012 May 02; 30(21):3239-47. PubMed ID: 22094282
    [Abstract] [Full Text] [Related]

  • 5. Control of pertussis--lessons learnt from a 10-year surveillance programme in Sweden.
    Carlsson RM, Trollfors B.
    Vaccine; 2009 Sep 25; 27(42):5709-18. PubMed ID: 19679218
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.
    Rendi-Wagner P, Paulke-Korinek M, Stanek G, Khanakah G, Kollaritsch H.
    Pediatr Infect Dis J; 2007 Sep 25; 26(9):806-10. PubMed ID: 17721375
    [Abstract] [Full Text] [Related]

  • 9. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.
    de Greeff SC, Mooi FR, Schellekens JF, de Melker HE.
    Pediatr Infect Dis J; 2008 Mar 25; 27(3):218-23. PubMed ID: 18277916
    [Abstract] [Full Text] [Related]

  • 10. [Monitoring of a whooping cough epidemic 1994/95 in Switzerland using the sentinel notification system. Sentinella Registry].
    Matter HC, Schmidt-Schläpfer G, Zimmermann H.
    Schweiz Med Wochenschr; 1996 Aug 24; 126(34):1423-32. PubMed ID: 8848704
    [Abstract] [Full Text] [Related]

  • 11. Control of pertussis in the world.
    Galazka A.
    World Health Stat Q; 1992 Aug 24; 45(2-3):238-47. PubMed ID: 1462658
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Vaccine protection of Swedish children. Time for revision of replacing doses of diphtheria, tetanus, polio and pertussis].
    Olin P.
    Lakartidningen; 2001 Aug 29; 98(35):3654-7. PubMed ID: 11577639
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA, Halperin SA, De Serres G, Scheifele DW, Tam T.
    Pediatr Infect Dis J; 2007 Jan 29; 26(1):31-5. PubMed ID: 17195702
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose.
    Hallander HO, Gustafsson L, Ljungman M, Storsaeter J.
    Vaccine; 2005 Nov 16; 23(46-47):5359-64. PubMed ID: 16051400
    [Abstract] [Full Text] [Related]

  • 19. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
    Hendrikx LH, de Rond LG, Oztürk K, Veenhoven RH, Sanders EA, Berbers GA, Buisman AM.
    Vaccine; 2011 Aug 05; 29(34):5725-30. PubMed ID: 21669247
    [Abstract] [Full Text] [Related]

  • 20. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M, Habermehl P, Faber J, Bock HL, Sänger R, Bogaerts H, Clemens R, Schuind A, du Prel JB, Schmitt HJ.
    Vaccine; 2006 Jul 07; 24(27-28):5627-36. PubMed ID: 16740348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.